0 likes | 2 Views
U.S. Prefilled Syringes Market
E N D
The U.S. prefilled syringes market report analyzes the $2.87 billion market (2023) projected to grow at 11.3% CAGR through 2032. Key findings include: Market Segments: Materials: Glass dominates but plastic syringes gaining adoption Closing Systems: Staked needle systems lead, with luer lock systems growing Design: Single-chamber syringes hold largest share End Users: Pharmaceutical companies are primary users Key Drivers: Shift toward biologics and specialty drugs Rising R&D investment in new products Growing chronic disease patient population Notable Developments: BD launched Effivax glass prefillable syringe (Sept 2022) CSL received FDA approval for Hizentra 50ml prefilled syringe (April 2023) AstraZeneca gained approval for self-administered Tezspire (Feb 2023) Market Leaders: Becton Dickinson and Company Gerresheimer AG SCHOTT AG Report- Fortune Business Insights - U.S. Prefilled Syringes Market Share, Growth Report https://www.fortunebusinessinsights.com/u-s-prefilled-syringes-market-107976